soul trial oral semaglutide cardiovascular outcomes results 2025 nejm New in the May 29, 2025, issue of NEJM: Sotatercept in Pulmonary Arterial Hypertension (ZENITH phase 3 trial) https://nej.md/4iYkLbj and (SOUL trial) https://nej.md/4hHII5M Upadacitinib for Giant-Cell Arteritis Oral Semaglutide and Cardiovascular Outcomes
Description
Meanwhile, researchers and doctors are concerned that some of these online companies aren't properly screening or monitoring patients
Retatrutide vs Tirzepatide UK (2026) Research Guide
Metro areas
Clinician eligibility review
Food and Drug Administration (FDA) The U.S
